ReviewTherapeutic advances in medical oncology2017

Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice.

Petra Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.